Thematic Area: 
Autosomal Dominant Polycystic Kidney Disease   

An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

Reference: Müller RU, Messchendorp AL, Birn H, et al. Nephrol Dial Transplant. (2022). doi: 10.1093/ndt/gfab312

Collaboration: ERKNet, ERA, Polycystic Kidney Disease International

International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people

Reference: Gimpel C, Bergmann C, Bockenhauer D, et al. Nat Rev Nephrol. (2019). doi: 10.1038/s41581-019-0155-2

Autosomal Dominant Polycystic Kidney Disease (ADPKD): Executive Summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Reference: Chapman AB, Devuyst O, Eckardt KU, et al. Kidney Int. (2015). doi: 10.1038/ki.2015.59